Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients.
Eculizumab, Neuromyelitis Optica, and Tuberculosis: We Live An Era of Challenging Combinations.
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Analysis of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2014 In Spain.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
Statins and Neuroprotection: Basic Pharmacology Needed.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
B-Cell Targeting Agents in the Treatment of Multiple Sclerosis.
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study.
Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody.
Myelin repair in vivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF).
Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome.
The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed towards Multiple Epitopes in C57BL/6-Immunized Mice.
Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis.
Targeting cells in motion: migrating toward improved therapies.
Using historical control information for the design and analysis of clinical trials with overdispersed count data.

Pages